Dose-response analysis of tirzepatide and acute pancreatitis: An international systematic review and quantitative meta-analysis of randomised trials - PubMed
5 hours ago
- #dose-response meta-analysis
- #tirzepatide
- #acute pancreatitis
- Acute pancreatitis risk with tirzepatide is very rare (0.22%) in included randomized trials.
- No significant dose-response relationship found for tirzepatide doses of 5, 10, and 15 mg regarding pancreatitis risk.
- Study limitations include industry funding, short follow-up, and low event rates affecting precision.